(D-Pro¹⁹⁴)-IL-1β (193-195) (human) |
| Katalog-Nr.GA20152 |
KdPT, a D-Pro-modified analog of IL-1β (193-195), antagonizes the hyperalgesia evoked by IL-1β in a dose-dependent manner. Therefore, it may be considered as the prototype for a new class of analgesic drugs.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 117027-34-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
KdPT, a D-Pro-modified analog of IL-1β (193-195), antagonizes the hyperalgesia evoked by IL-1β in a dose-dependent manner. Therefore, it may be considered as the prototype for a new class of analgesic drugs.
Average Rating: 5 (Based on Reviews and 5 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *